`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ALEMBIC PHARMACEUTICALS, LTD.,
`Petitioner,
`
`v.
`
`RESEARCH CORPORATION TECHNOLOGIES, INC.,
`Patent Owner.
`
`Case No. IPR2016-01245
`Patent No. RE 38,551
`
`PATENT OWNER’S UPDATED MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Patent No. RE 38,551
`
`
`
`Case No. IPR2016-01245
`
`
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner Research Corporation
`
`Technologies, Inc. submits the following Updated Mandatory Notices to provide
`
`an update regarding related matters involving RE 38,551. All other information
`
`remains unchanged.
`
`A. Related Matters Under 37 C.F.R. § 42.8(b)(2)
`
`The related judicial proceedings involving RE 38,551 are shown below. On
`
`August 12, 2016, an Order issued in 1:13-cv-01206-LPS (consolidated) (Ex. 2004),
`
`intending to enter final judgment for the plaintiffs/patent owner against the
`
`defendants consistent with the Memorandum Opinion unsealed on August 15, 2016
`
`(Ex. 2003). See, e.g., Ex. 2003 at 86–91.
`
`Case Caption
`UCB, Inc. et al. v. Teva Pharmaceuticals USA Inc.
`et al., 1:13-cv-01148-LPS (D. Del.)
`UCB, Inc. et al. v. Accord Healthcare Inc. et al.,
`1:13-cv-01206-LPS (D. Del.)
`UCB, Inc. et al. v. Alembic Pharmaceuticals Ltd.,
`1:13-cv-01207-LPS (D. Del.)
`UCB, Inc. et al. v. Amneal Pharmaceuticals, LLC
`et al., 1:13-cv-01208-LPS (D. Del.)
`UCB, Inc. et al. v. Apotex Corp. et al., 1:13-cv-
`01209-LPS (D. Del.)
`UCB, Inc. et al. v. Aurobindo Pharma Ltd. et al.,
`1:13-cv-01210-LPS (D. Del.)
`UCB, Inc. et al. v. Breckenridge Pharmaceutical
`Inc. et al., 1:13-cv-01211-LPS (D. Del.)
`UCB, Inc. et al. v. Glenmark Generics Inc. USA et
`al., 1:13-cv-01212-LPS (D. Del.)
`UCB, Inc. et al. v. Hetero USA Inc. et al., 1:13-cv-
`01213-LPS (D. Del.)
`
`1
`
`Disposition
`closed
`
`pending
`
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`closed
`
`closed
`
`
`
`Patent No. RE 38,551
`
`
`
`Case No. IPR2016-01245
`
`
`
`Case Caption
`UCB, Inc. et al. v. Mylan Pharmaceuticals Inc. et
`al., 1:13-cv-01214-LPS (D. Del.)
`UCB, Inc. et al. v. Ranbaxy Laboratories Ltd. et
`al., 1:13-cv-01215-LPS (D. Del.)
`UCB, Inc. et al. v. Sandoz Inc., 1:13-cv-01216-
`LPS (D. Del.)
`UCB, Inc. et al. v ScieGen Pharmaceuticals Inc. et
`al., 1:13-cv-01217-LPS (D. Del.)
`UCB, Inc. et al. v Sun Pharma Global FZE et al.,
`1:13-cv-01218-LPS (D. Del.)
`UCB, Inc. et al. v. Watson Laboratories Inc. -
`Florida et al., 1:13-cv-01219-LPS (D. Del.)
`UCB, Inc. et al. v. Zydus Pharmaceuticals (USA)
`Inc. et al., 1:13-cv-01220-LPS (D. Del.)
`UCB, Inc. et al. v. Apotex Corp. et al., 1:14-cv-
`00834-LPS (D. Del.)
`UCB, Inc. et al. v. Sun Pharma Global FZE et al.,
`1:13-cv-05514 (N.D. Ill.)
`UCB, Inc. et al. v. Zydus Pharmaceuticals (USA),
`Inc. et al., 3:13-cv-04021 (D.N.J.)
`UCB, Inc. et al. v. Aurobindo Pharma Ltd. et al.,
`1:16-cv-00451 (D. Del.)
`UCB, Inc. et al. v. Hetero USA Inc. et al., 1:16-cv-
`00452 (D. Del.)
`
`
`Disposition
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`closed
`
`closed
`
`closed
`
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`closed
`
`closed
`
`pending
`
`pending
`
`2
`
`
`
`Patent No. RE 38,551
`
`Case No. IPR2016—01245
`
`Date: August 19, 2016
`
`Respectfully submitted,
`
`5%4%___
`
`drea G. Reister
`
`Registration No. 36,253
`Jennifer L. Robbins
`
`Registration No. 61,163
`COVINGTON & BURLING LLP
`
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`(202) 662-6000
`
`Attorneys for Patent Owner
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 19th day of August
`
`2016, the foregoing Patent Owner’s Updated Mandatory Notices Under 37
`
`C.F.R. § 42.8 was served by electronic mail, by agreement of the parties, on the
`
`following counsel of record for Petitioner.
`
`Gary J. Speier (gspeier@carlsoncasperscom)
`Jeffer Ali Gali@carlsoncaspers.com)
`Carlson, Caspers, Vandenburgh, Lindquist and Schuman,
`P.A.
`
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`
`Date: August 19, 2016
`
`
`
`Jennifer L. Robbins, Esq.
`Registration No.: 61,163